Preferred Label : Familial Primary Pulmonary Hypertension;

MeSH definition : Familial or idiopathic hypertension in the PULMONARY CIRCULATION which is not secondary to other disease.;

MeSH synonym : Heritable Pulmonary Arterial Hypertension;

MeSH hyponym : pulmonary hypertension, primary, Fenfluramine-Associated; pulmonary hypertension, primary, Dexfenfluramine-Associated;

Related MeSH term : Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia; idiopathic pulmonary arterial hypertension; Primary Pulmonary Hypertension; Hypertension, Primary Pulmonary; Hypertensions, Primary Pulmonary; Primary Pulmonary Hypertensions; Pulmonary Hypertension, Primary; Pulmonary Hypertensions, Primary; Idiopathic Pulmonary Hypertension; Hypertension, Idiopathic Pulmonary; Hypertensions, Idiopathic Pulmonary; Idiopathic Pulmonary Hypertensions; Pulmonary Hypertension, Idiopathic; Pulmonary Hypertensions, Idiopathic; Pulmonary Hypertension, Primary, 1; Pph1 With Hht; Hht, Pph1 With; Hhts, Pph1 With; Pph1 With Hhts; With Hht, Pph1; With Hhts, Pph1;

Details


Main resources

You can consult :

Familial or idiopathic hypertension in the PULMONARY CIRCULATION which is not secondary to other disease.

http://www.has-sante.fr/portail/jcms/c_2583127/fr/opsumit
http://www.has-sante.fr/portail/jcms/c_2583127/fr/opsumit-macitentan-antagonistes-des-recepteurs-de-l-endotheline
2015
false
false
false
France
French
evaluation of the transparency committee
macitentan
hypertension, pulmonary
adult
administration, oral
macitentan
treatment outcome
drug therapy, combination
idiopathic pulmonary arterial hypertension
Pulmonary arterial hypertension associated with connective tissue disease
Pulmonary arterial hypertension associated with congenital heart disease
orphan drug production
Endothelin A Receptor Antagonists
Endothelin B Receptor Antagonists
Familial Primary Pulmonary Hypertension
guidelines for drug use
Product containing macitentan in oral dose form (medicinal product form)
pyrimidines
sulfonamides

---
http://www.has-sante.fr/portail/jcms/c_1769783/fr/opsumit
2014
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
macitentan
macitentan
hypertension, pulmonary
adult
administration, oral
macitentan
treatment outcome
drug therapy, combination
idiopathic pulmonary arterial hypertension
Pulmonary arterial hypertension associated with connective tissue disease
Pulmonary arterial hypertension associated with congenital heart disease
orphan drug production
Endothelin A Receptor Antagonists
Endothelin B Receptor Antagonists
Endothelin A Receptor Antagonists
Endothelin B Receptor Antagonists
Familial Primary Pulmonary Hypertension
Product containing macitentan in oral dose form (medicinal product form)
pyrimidines
sulfonamides
pyrimidines
sulfonamides

---
https://anpgm.fr/media/documents/ANPGM_105_Hypertension_pulmonaire.doc
2012
France
guideline
Pulmonary hypertension
unknown (origin)
pulmonary hypertension, nos
Familial Primary Pulmonary Hypertension
hypertensive disease, nos

---
Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.